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1. OVERVIEW
In a health perspective the need for the analysis of gene
sequences, oxidative damage to DNA and the understand-
ing of DNA interactions with molecules or ions led to the
development of DNA-based biosensors. The DNA-based
biosensor is a device that incorporates immobilized DNA as
molecular recognition element in the biological active layer
on the surface, and measures specific binding processes with
DNA mainly using electrochemical, optical and piezoelectric
transducers. The fact that the DNA sequences are unique
to each organism means that any self-replicating biological
organism can be discriminated.
The DNA-based biosensor is also a complementary tool
for the study of biomolecular interaction mechanisms of
compounds with DNA, enabling the screening and evalua-
tion of the effect caused to DNA by health hazardous com-
pounds and oxidizing substances. There are hundreds of
compounds which bind and interact with DNA. Exposure to
toxic chemicals is the cause of many human cancers; these
carcinogens act by chemically damaging the DNA. Thus it is
very important to explain the factors that determine affinity
and selectivity in binding molecules to DNA, identify these
chemicals and ascertain their potency so that human expo-
sure to them can be minimized.
The reactions with chemicals cause changes in the struc-
ture of DNA and the base sequence leading to perturbations
in DNA replication. A quantitative understanding of the rea-
sons that determine selection of DNA reaction sites is useful
in designing sequence-specific DNA binding molecules for
application in chemotherapy and in explaining the mecha-
nism of action of neoplasic drugs.
Electrochemical techniques have the advantage in DNA-
biosensor design of having a rapid response time, being
quantitative, sensitive, suitable for automation, cost effective,
disposable, enabling in situ generation of reactive interme-
diates and detection of DNA damage and solving analytical
problems in a wide range of contexts in order to be com-
mercially viable. Comprehensive descriptions of research on
DNA and DNA sensing [1–10] show the great possibilities
of using electrochemical transduction in DNA diagnostics.
2. DNA-ELECTROCHEMICAL
BIOSENSORS
Electrochemical research on DNA is of great relevance
to explain many biological mechanisms. The DNA-
electrochemical biosensor is a very good model for simulat-
ing nucleic acid interaction with cell membranes, potential
environmental carcinogenic compounds and for clarifying
the mechanisms of action of drugs used as chemotherapeu-
tic agents. An electrochemical sensor for detecting DNA
damage consists of an electrode with DNA on its sur-
face. DNA-electrochemical biosensors enable the study of
the interaction of DNA immobilized on the electrode sur-
face with analytes in solution, the DNA acting as a pro-
moter between the electrode and the biological molecule
under study. Interactions of the surface-confined DNA with
a DNA damaging agent are converted, via changes in elec-
trochemical properties of the DNA recognition layer, into
measurable electrical signals [11]. The interaction of a num-
ber of substances with DNA has been successfully studied
using such a kind of biosensor and the interpretation of
results have contributed to the elucidation of the mecha-
nisms by which DNA is damaged by hazardous compounds
[12–16].
When compared with optical, piezoelectric or other trans-
ducers the electrochemical transduction is dynamic in that
the electrode is itself a tuneable charged reagent as well as
a detector of all surface phenomena, which greatly enlarges
the electrochemical DNA biosensing capabilities. However,
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it is necessary that the analyte is electroactive, i.e., capable
of undergoing heterogeneous electron transfer reactions, in
order to use an electrochemical transducer. To design DNA-
based biosensors, it is essential to understand the surface
structures of the modified surfaces and so it is important to
know which DNA groups are electroactive.
The double helical structure of DNA consists of two
polynucleotide chains running in opposite directions and
made up of a large number of deoxyribonucleotides, each
composed of a base, a sugar, and a phosphate group. The
four different bases, Scheme 1, the purines, adenine (A) and
guanine (G), and pyrimidines, thymine (T) and cytosine (C)
which are all electroactive [6, 17, 18] are on the inside of the
double helix and their distance and accessibility to the elec-
trode surface is determinant for nucleic acids’ electrochem-
ical behavior. The electrochemical behavior of DNA and
adsorption at different types of electrodes has been investi-
gated for a number of years first using a dropping mercury
electrode and more recently solid electrodes [6, 7].
The electrochemical behavior with double strand DNA
(dsDNA) and single strand DNA (ssDNA) illustrates the
greater difficulty for the transition of electrons from the
inside of the double-stranded rigid form of DNA to the elec-
trode surface, than from the flexible single-stranded form of
DNA where the guanine and adenine residues are in close
proximity to the electrode surface. The roughness of a solid
electrode surface means that dsDNA has some difficulty
in following the surface contours whereas unwound ssDNA
molecules fit more easily into the grooves on the electrode
surface, because of their greater flexibility. Differential pulse
voltammograms obtained with a bare glassy carbon elec-
trode (GCE) did not show any oxidation peak for dsDNA
in the first voltammogram, Fig. 1. The very small peaks that
appeared after forty scans were caused by changes in con-
formation of the double helix due to the positive applied
potential that enabled some guanine and adenine residues
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Scheme 1. Chemical structures of guanine (G), adenine (A), thymine
(T), and cytosine (C).
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Figure 1. Differential pulse voltammograms obtained with a bare GCE
in pH 4.5 0.1 M acetate buffer of: (•••) 15 M 8-oxoguanine (8-
oxoGua); (•••) 15 M guanine (G); (•••) 15 M guanosine (Guo);
(•••) 100 M adenine (A); and 60  g/ml dsDNA (- - -) 1st and (—)
40th voltammogram. Pulse amplitude 50 mV, pulse width 70 ms, scan
rate 5 mV s−1. Reprinted with permission from [14], A. M. Oliveira
Brett et al., Talanta 56, 969 (2002). © 2002, Elsevier.
to be more accessible to the electrode surface [14]. The dif-
ferential pulse voltammogram for the oxidation of dsDNA
using a small diameter GCE (d = 15 mm) in acetate buffer
showed better the two tiny signals corresponding to the oxi-
dation of guanosine and adenosine residues in the polynu-
cleotide chain [115].
Electrochemical oxidation on carbon electrodes [17–24]
showed that all bases–guanine (G), adenine (A), cytosine
(C) and thymine (T)–can be oxidized, Fig. 2, following a
pH dependent mechanism. The voltammetric studies on
DNA shown in this figure include all four bases—for the
first time equimolar mixtures of all DNA bases, nucleosides
and nucleotides have been quantified by differential pulse
voltammetry [18]. Electrochemical pre-conditioning of the
glassy carbon electrode enabled a better peak separation and
an enhancement of the current of the oxidation peaks for
all four DNA bases in pH 7.4 phosphate buffer supporting
electrolyte, close to physiological pH. Detection limits in the
nano- and micromolar range were obtained for purine and
pyrimidine bases, respectively, together in solution.
The results showed for the first time that the pyrimidine
nucleosides and nucleotides are electroactive on glassy car-
bon electrodes and that, besides the easy detection of the
purines, it was also possible to detect simultaneously the
oxidation of pyrimidine residues in ssDNA [18].
Electrochemical reduction of natural and biosynthetic
nucleic acids at a dropping mercury electrode (DME)
[1, 6, 12, 13] showed that adenine and cytosine residues
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Figure 2. Base line corrected differential pulse voltammograms
obtained in a 20 mM equimolar mixture of guanine (G), adenine (A),
thymine (T), and cytosine (C) in pH 7.4 0.1 M phosphate buffer sup-
porting electrolyte with: (a) 1.5 mm, (b) 7 m diameter GCE. Pulse
amplitude 50 mV, pulse width 70 ms, scan rate 5 mV s−1. Reprinted
with permission from [18], A. M. Oliveira-Brett et al., Anal. Biochem.
(2004). In press. © 2004.
as well as guanine residues in a polynucleotide chain are
reducible, Fig. 3. The cyclic voltammogram of ssDNA at
a hanging mercury drop electrode (HMDE) showed a
cathodic peak due to irreversible reduction of cytosine (C)
and adenine (A). The reduction of guanine (G) occurs at
very negative potentials but a peak due to the oxidation
of the reduction product of (G) could be detected in the
reverse scan [6].
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Figure 3. Cyclic voltammogram of ssDNA obtained upon repeated
cycling. (CA) peak due to reduction of C and A, (G) peak due to oxida-
tion of reduction product of G. Reprinted with permission from [6], E.
Palecek et al., in “The Encyclopedia of Electrochemistry” (A. J. Bard
and M. Stratmann, Eds.) in “Bioelectrochemistry” (George Wilson,
Ed.), Vol. 9, Ch. 12, p. 365 and references therein. Wiley-VCH Verlag,
Weinheim, FRG, 2002. © 2002, Wiley.
A critical issue in the development of a DNA-
electrochemical biosensor is the sensor material and the
degree of surface coverage that influences directly the sen-
sor response, so electrode surface characteristics represent
an important aspect in the construction of sensitive DNA-
electrochemical biosensors for rapid detection of DNA
interaction and damage.
The study of the adsorption of DNA at electrode surfaces
is of fundamental interest, since the interaction of DNA
with charged surfaces can be expected in biological systems.
In fact, a number of studies of DNA adsorption was con-
ducted at mercury electrodes [25–33] and carbon electrodes
[34, 35] and in general a weaker adsorption was observed
with dsDNA than with ssDNA.
Atomic Force Microscopy (AFM) has been proved to
be a powerful tool for obtaining high-resolution images of
adsorbed DNA. Images of DNA conformations, unusual
structures and DNA-protein complexes have been obtained.
However, the DNA molecules do not bind strongly enough
to conducting substrates and the AFM tip tends to sweep
away the adsorbed macromolecules. Magnetic AC mode
AFM (MAC Mode AFM) permits the visualization of the
molecules weakly bound to the substrate material and can
be very helpful in the investigation of molecules loosely
attached to the conducting surface of electrochemical trans-
ducers. MAC Mode AFM in an electrochemically-controlled
environment is capable of resolving the surface morpholog-
ical structure of nucleic acid adsorbates and contributes to
the understanding of the mechanism of adsorption and the
nature of DNA-electrode surface interactions.
Using ex situ MAC mode AFM [36–40] it was possible
to visualize directly the surface characteristics of dsDNA
films prepared on a highly oriented pyrolytic graphite
(HOPG) electrode. It was found that different immobi-
lization methodologies lead to structural changes on the
DNA biosensor surface and consequently different sensor
response. The HOPG surface is extremely smooth, which
enables the identification of the topography changes when
the surface is modified with dsDNA [39]. In Fig. 4 are AFM
images of a HOPG substrate modified by a thick and a thin
layer of dsDNA. The two different immobilization proce-
dures of dsDNA at the surface of a HOPG electrode have
been evaluated, the thin dsDNA adsorbed film forming a
network structure, with holes not covered by the molecular
film exposing the electrode surface, and the thick dsDNA
film completely covering the electrode surface with a uni-
form multilayer film, presenting a much rougher structure.
The dsDNA networks formed at the HOPG electrode
during the formation of thin dsDNA layers define different
active surface areas of the DNA electrochemical biosensor.
The uncovered regions may act as a system of microelec-
trodes with nanometer or micrometer dimensions, Fig. 5.
The two dimensional dsDNA networks form a biomaterial
matrix to attach and study other molecules.
The major problem encountered with electrodes modified
by a thin film of dsDNA is the fact that the electrode is
not completely covered allowing the diffusion of molecules
from bulk solution to the surface and their non-specific
adsorption. The thin film DNA-electrochemical biosensor in
a solution containing an electroactive hazard compound will
give an electrochemical signal with two contributions. One
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Figure 4. MAC mode AFM topographical images in air of: (A1 and A2) clean HOPG electrode surface; (B1 and B2) thin film dsDNA-biosensor
surface, prepared onto HOPG by 3 min free adsorption from a solution of 60 g/ml dsDNA in pH 4.5 0.1 M acetate buffer electrolyte; (C1 and
C2) thick film dsDNA-biosensor surface, prepared onto HOPG by evaporation from solution of 37.5 mg/ml dsDNA in pH 4.5 0.1 M acetate buffer
electrolyte; (A1, B1, and C1) two-dimensional view 1 m × 1 m scan size and (A2, B2, and C2) three-dimensional view 500 nm × 500 nm scan
size. Reprinted with permission from [39], A. M. Oliveira Brett and A.-M. Chiorcea, Bioelectrochemistry 63, 229 (2004). © 2004, Elsevier.
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Figure 5. MAC mode AFM topographical image in air of thin dsDNA-
biosensor surface, prepared by applying an adsorption potential of
+300 mV (vs. Ag wire) to the HOPG electrode immersed into a
60  g/mL dsDNA pH 7.0, 0.1 M phosphate buffer electrolyte solution;
three-dimensional view 500 nm×500 nm scan size.
of these is from the electron transfer reaction of electroac-
tive hazard compound simply adsorbed on the uncovered
areas, Figs. 4, 5 and (7)C. The other is from the damage
caused by the hazard compound to the immobilized dsDNA
on the electrode surface, Figs. 4 and (8)C, and it is difficult
to distinguish between the two signals [14].
The big advantage of the thick film of dsDNA is that the
electrode surface is completely covered by dsDNA so that
undesired binding of molecules to the electrode surface is
impossible, Figs. 4 and (8)C. The DNA biosensor response
is thus only determined by the interaction of the compound
with the dsDNA in the film, without any contribution from
the electrochemical reaction of the compound at the sub-
strate surface.
Other forms of carbon besides HOPG electrodes, such
as glassy carbon electrodes (GCE) or carbon paste elec-
trodes (CPE), are usually used as the sensor material in
a DNA-electrochemical biosensor and substrate for DNA
immobilization but it is considered that the interactions,
the adsorption and the degree of surface coverage, between
DNA and the different carbon surfaces are very similar.
3. ELECTROCHEMICAL DETECTION OF
DAMAGE TO DNA BASES
Oxidative DNA damage caused by oxygen-free radicals leads
to multiple modifications in DNA, including base-free sites
and oxidized bases. The damage caused to DNA bases is
potentially mutagenic [41–47].
The major product of DNA oxidative damage
is 8-oxo-7,8-dihydroguanine (8-oxoGua), Fig. 1, an
electroactive compound which is the product of oxidation of
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Scheme 2. Oxidation mechanism of guanine.
guanine, Scheme 2, the most easily oxidized base in DNA
[7], Figs. 1 and 2. This modified base is highly mutagenic
[48, 49] causing G → T transversion and loss of base-pairing
specificity [50–52]. Since it was first reported two decades
ago [53], 8-oxoGua, namely its deoxynucleoside 8-oxo-
7,8-dihydro-2′deoxyguanosine (8-oxodGuo), Scheme 3, has
been the subject of intensive investigation and has become
widely accepted as a biomarker of oxidative DNA damage
and cellular oxidative stress [52–56]. Also 8-oxoGua and
8-oxodGuo are major products of DNA oxidative damage
that can be enzymatically repaired, being excreted into
urine.
Elevated levels of 8-oxodGuo were found in the urine
and lung tissues of smokers [57, 58] as well as in body flu-
ids and DNA from human tissues of patients with disor-
ders such as cancer, atherosclerosis, chronic hepatitis, cys-
tic fibrosis, diabetes, acquired immunodeficiency syndrome,
neurodegenerative and age-related diseases [56, 59–62]. One
approach to assess this oxidative DNA damage is the
measurement of 8-oxoGua or 8-oxodGuo content in DNA
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Scheme 3. Chemical structures of 8-oxo-7,8-dihydroguanine (8-
oxoGua), 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodGuo) and uric
acid (UA).
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isolated from tissues that would represent steady-state lev-
els arising from the balance between oxidative damage and
enzymatic repair [55].
Endogenous production of 8-oxoGua due to aerobic cel-
lular metabolism leads to basal levels of one 8-oxoGua/106
DNA bases, being excreted into urine at basal concen-
trations below 100 nM [63]. Due to their high sensitivity,
voltammetric techniques enable the detection of such low
concentrations of 8-oxoGua [64]. In urine, purines such as
hypoxanthine and uric acid (UA) are co-excreted in concen-
trations 104-fold higher than 8-oxoGua. UA is the major end
product of purine metabolism in humans and its levels in
urine are also indicative of various diseases. It has a struc-
ture very similar to 8-oxoGua, Scheme 3, and is thus a strong
interferent. Assessment of urinary levels of both 8-oxoGua
and 8-oxodGuo may provide a non-invasive approach to
evaluate the DNA repair capability in individuals and be
used as biomarkers of cellular oxidative stress.
At present, HPLC with electrochemical detection (HPLC-
ECD) is the most commonly used technique to assess
urinary 8-oxodGuo, but HPLC with tandem mass spectrom-
etry (HPLC-MS/MS) is also being used, showing high sensi-
tivity and a better specificity. However, HPLC-ECD is easier
to use and less demanding of resources. There is a significant
lack of HPLC-ECD based methods for 8-oxoGua detection
in human urine, despite 8-oxoGua being also electrochem-
ically detectable [64] at a lower potential than 8-oxodGuo
[65]. A selective method based on HPLC-ECD was devel-
oped to enable simultaneous detection of 8-oxoGua and
8-oxodGuo, products of DNA oxidative damage, after UA
elimination by uricase, consisting of HPLC isocratic elu-
tion with amperometric detection, enabling a detection limit
for 8-oxoGua and 8-oxodGuo lower than 1 nM in stan-
dard mixtures [66, 67]. Regardless of the complexity and
inter-individual variability of urine samples, the method was
tested with urine samples from children (3–8 years old) with
metabolic disorders [66], Fig. 5, and it was confirmed that at
the applied working potential, hypoxanthine does not give
any electrochemical signal [68] and does not interfere at all
in 8-oxoGua signal.
The oxidation of the other DNA bases, Fig. 2, is much
more difficult due to their high oxidation potentials. Chem-
ical modification of each of the DNA bases causes molec-
ular disturbance to the genetic machinery that leads to cell
malfunction and death. For instance, oxidative DNA dam-
age by free radicals and exposition to ionizing radiation
generates several products within the double helix besides
8-oxoguanine, such as 2,8-oxoadenine, 5-formyluracil, 5-
hydroxicytosine, etc. which are mutagenic [41]. It is well
established that the oxidation of DNA bases is an important
source of genomic instability since there is evidence that the
oxidation products of DNA bases play an important role in
mutagenesis, carcinogenesis, ageing and age-related disease
[41, 47, 69].
Hence, great interest exists in the sensitive determina-
tion and full characterization of the mechanisms involved in
oxidative damage of all DNA bases. Electrochemical meth-
ods are very promising for the study of DNA oxidative dam-
age as well as in the investigation of the mechanisms of
interaction of drugs with DNA [6–10]. In particular, electro-
chemical DNA-biosensors have proved to be excellent tools
for investigating the effect of various endogenous and exoge-
nous sources of hazard on genomic material, allowing quick
and low cost determination of DNA damage.
4. ELECTROCHEMICAL DETECTION
OF DNA DAMAGE
As indicated above, many compounds bind and interact with
DNA. Toxic chemicals damage DNA and can cause human
cancers. The changes in the structure of DNA and the
base sequence can lead to perturbation in DNA replication.
The products of oxidation of DNA bases lead to substitu-
tions, deletions and insertions in the base sequence of DNA,
the process called mutagenesis [70]. The clarification of the
mechanisms that determine affinity and selectivity in binding
molecules to DNA, enabling a quantitative understanding
of the reasons that determine selection of DNA reaction
sites, is useful in designing sequence-specific DNA binding
molecules for application in chemotherapy and in explaining
the action of neoplasic drugs [71].
The DNA interacting drugs prevent cell growth, but not
only cancer cell growth; the cytotoxic effect also blocks the
growth of normal cells. The lack of selectivity of cancer
drugs is one of the main problems in cancer chemotherapy
and DNA-biosensors are an important tool for the investi-
gation of the chemical and biological mechanism of drugs
which are active against cancer cells.
Electrochemical methods [11] have shown great poten-
tial in studying the adsorption and reactions of biological
molecules at electrified interfaces. They have been used
by a number of researchers who have been studying metal
ion-DNA interactions [72, 73]. Using DNA-electrochemical
biosensors, electrochemical methods will probe DNA inter-
actions and will continue to exploit the remarkable speci-
ficity of biomolecular recognition to provide analytical tools
that can measure the presence of a single molecular species
in a complex mixture, pre-screen hazard compounds that
cause damage to DNA and help to explain DNA-protein
interactions.
The possible relation between oxidative damage and
metal ion concentrations is not completely clear. Metal ions
such as Na+, K+, Mg2+, and Ca2+ exist in the body in high
concentrations and the nucleic acids and nucleotides occur
as complexes coordinated with these ions. A metal ion has
four different potential coordination sites for binding with
DNA: the negatively charged phosphate oxygen atoms, the
ribose hydroxyls, the base ring nitrogens and the exocyclic
base keto groups.
There are many forms that a metal ion can take but it
is the free metal ion that is most toxic and trace levels
of free toxic metals, such as copper, cadmium, lead and
zinc, can be determined using electrochemical methods
[73–75]. The heavy (or transition) metal elements, cad-
mium, chromium and nickel, are carcinogenic and the most
toxic metals known. They catalyse the formation of highly
reactive species causing DNA damage, and its site speci-
ficity is determined by the chemical property of the reactive
species formed. Thus, metal-catalyzed ROS generation may
play a critical role in carcinogenesis induced by chemicals.
It is accepted that DNA adduct formation participates in
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tumor initiation [76], while oxidative DNA damage would
be involved in tumor promotion [77].
Nevertheless, the mechanism of metal carcinogenesis is
not clear due to the very complex nature of metal interac-
tions in biological systems. Metal ions react with superoxide
anion (O−2  and H2O2 to produce highly reactive species
such as hydroxyl free radicals (OH) and metal-oxygen com-
plexes in biological systems, resulting in metal-mediated
oxidative DNA damage.
Studies of metallointercalation agents [78–80] in the
presence of dsDNA have been done with solutions con-
taining the redox complexes Co(phen)3+/2+3 , Fe(phen)
2+/3+
3 ,
Co(bpy)3+/2+3 , Fe(bpy)
2+/3+
3 , and Os(bpy)
2+/3+
3 (where
phen = 1,10-phenanthroline and bpy = 2,2′-bipyridyl). Bind-
ing was interpreted in terms of the interplay of electrostatic
interactions of the metal coordination complexes with the
charged sugar-phosphate and the intercalative, hydrophobic,
interactions within the DNA helix, i.e., the stacked base
pairs. Chronopotentiometric detection of the Co(bpy)3+3
indicator was used [81] to monitor the hybridization onto
a screen-printed carbon electrode of short DNA sequences
from E. coli pathogen in environmental water samples. The
redox couple Co(bpy)3+/2+3 was also used to evaluate the
adsorption of DNA on gold electrodes [81–83].
Studies of redox-active metallointercalation agents in the
presence of dsDNA have been done with solutions con-
taining the redox complexes of cobalt, iron and osmium
[5, 6, 10, 13, 84]. Osmium tetroxide complexes with tertiary
amines (Os, L) have been used as a chemical probe of DNA
structure. The simultaneous determination of (Os, L)-DNA
adducts and free (Os, L) using a pyrolitic graphite electrode
was possible due to their peak separation on the potential
scale being sufficiently large.
Layer-by-layer electrostatic assembly of DNA, enzymes,
polyions, and catalytic redox polyions of nanometer thick-
ness on electrodes, were designed to detect DNA damage
as they can provide active elements for sensors for screen-
ing the toxicity of chemicals and their metabolites, and for
oxidative stress [85, 86].
Metallopolyion films catalyze DNA oxidation and were
incorporated into DNA/enzyme films enabling the detection
of structural damage to DNA as a basis for toxicity screening
and leading to “reagentless” sensors. Films of the osmium
polymer [Os(bpy)2(PVP)10Cl]+[PVP=poly(vinylpyridine)]
were used to monitor DNA oxidation selectively; including
the analogous ruthenium metallopolymer in the sensor
provides a monitor for oxidation of other nucleobases
[85, 86].
The binding of ligand and ligand substituents in com-
plexes of ruthenium(II) [87] has been investigated in a sys-
tematic fashion and the binding parameters for the series
compared in order to determine the different ligand func-
tionalities and sizes in the binding with DNA, i.e., intercala-
tion and surface binding. It was found that if one compares
the various factors that contribute to stabilizing the metal
complexes of ruthenium on the DNA helix it appears that
the most significant factor is that of molecular shape. The
complexes that fit most closely to the DNA helical struc-
ture, those in which the van der Waals interactions between
complex and DNA are maximized, display highest binding
affinity.
A doubly metallated 15 base-pair double helix contain-
ing ruthenium and rhodium at each end of the strands [87]
showed the efficiency of DNA for coupling electron donors
and acceptors over a very long range, greater then 4 nm.
The dsDNA was found to behave like a piece of molecular
wire with fast electron transfer rates (≥1010 s−1 for the pho-
toinduced electron transfer between the metallointercalators
[88–90] and semiempirical Hartree-Fock calculations of HAB
for DNA mediated electron transfer [91] were described.
Oxidative damage to DNA was demonstrated to depend
upon oxidation potential [92] and be promoted from a
remote site as a result of an electron hole migration through
the DNA -stack, the hole migrates down the double helix
to damage guanine, a site sensitive to oxidative nucleic acid
damage within the cell.
During the transfer of genetic information, the interac-
tions between DNA and the divalent ions Mg2+, Mn2+,
Co2+, Cu2+, Zn2+, Ni2+, Cr2+, Cd2+, and Pb2+ play an essen-
tial role in promoting and maintaining the nucleic acid func-
tionalities. Some are recognized for their carcinogenicity
as they damage DNA molecules and alter the fidelity of
DNA synthesis [93, 94]. Nickel, chromium, and cadmium,
have been recognized as the most effective carcinogens.
Many inorganic nickel compounds have been tested and
their effect on a cell or tissue has been established as an
interaction with the base donor systems, especially within
unwound parts of nucleic acids [95–97]. Damage to DNA
structure has also been described due to the effects of Zn
[98], Cd [98], and Pb [99]. The interaction modes of metallo-
porphyrins with DNA [100] have a different electrochemical
behavior depending on the metal ions: Cu, Ni, Zn, or Cd,
and the porphyrin ligands.
The adsorptive and voltammetric characteristics of Cu(II)
complexes with guanine, guanosine and adenosine were
exploited [101] in order to detect these bases after separa-
tion by capillary zone electrophoresis and the enzyme-mimic
catalytic activity of a DNA-Cu2+ complex [102] was used to
develop an amperometric quinacrine sensor using an oxygen
electrode covered by the complex entrapped in polyacry-
lamide gel.
The cytostatic activity of various platinum drugs has
shown that platinum coordination complexes cause irre-
versible inhibition of DNA synthesis due to covalent bind-
ing with DNA [100]. This often causes the treatment to
be accompanied by adverse reactions. Differential pulse
voltammetry with the static mercury drop electrode has been
used to investigate the interactions of a group of eight
anticancer-active Pt(II) and Pt(IV) complexes in solution
with DNA, as well as the conformational alterations induced
by the binding of the drugs [104–108]. The interactions of
carboplatin in solution with DNA were investigated using
differential pulse voltammetry at a glassy carbon modified
electrode [97, 98]. It was found that the binding of platinum
drugs causes local distortions in the DNA molecule with
the formation of interstrand cross-links. Research on metal
ion nucleic acid complexes was advanced when antitumour
activities of platinum (II) compounds were discovered.
Similarly, the detection of DNA damage involving
strand breaks was observed [109] using a hanging mercury
drop electrode (HMDE). Extensive cleavage of electrode-
confined DNA by reactive oxygen species (ROS) was
8 Electrochemistry for Probing DNA Damage
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Figure 6. (A) Chromatograms obtained from (•••) 10 L injection of a 100 nM standard mixture of UA, 8-oxoGua and 8-oxodGuo and (—) 10 L
injection of an urine sample from a child with metabolic disorders, after being processed by SPE. Same urine sample (—) before and (•••) after
being spiked with 250 nM standard solutions of (B) 8-oxoGua and (C) 8-oxodGuo. Mobile phase: 50 mM phosphate buffer + 6% MeOH+2 mM
KCl, final pH 6.2. Reprinted with permission from [66], I. A. Rebelo et al., Talanta 63, 323 (2004). © 2004, Elsevier.
obtained in the absence of chemical reductants when redox
cycling of the metal (iron/DNA complex) was controlled.
Not only the cleaving agents were detected but also the
DNA cleavage was modulated, by generating the DNA-
damaging species electrochemically.
Metals are considered to act not only as carcinogens but
also to activate carcinogenic chemicals. A number of aro-
matic compounds induce oxidative DNA damage through
metal catalyzed reactive oxygen species (ROS) generation.
There is a deep interest in identifying free radical scavengers
or antioxidants that inhibit oxidative DNA damage. Owing
to their polyphenolic nature, flavonoids, compounds found
in rich abundance in all land plants, often exhibit strong
antioxidant properties [110–112]. Initially, flavonoids were
investigated as potential chemopreventive agents against
certain carcinogens. Previous intake of a large quantity of
flavonoid inhibited the incidence of ROS produced dam-
age to DNA. In sharp contrast with the commonly accepted
role, there is also considerable evidence that flavonoids
themselves are mutagenic and have DNA damaging ability
[111, 112].
One example is quercetin, which under certain circum-
stances acts as a prooxidant and has mutagenic activity
[113, 114]. There is experimental evidence that the forma-
tion of quercetin radicals via autooxidation leads to the
generation of superoxide radicals. Also, it is proposed that
quercetin can directly reduce transition metals, thus pro-
viding all the elements necessary to generate the highly
oxidizing radical OH. Therefore, quercetin can promote
oxidative damage to DNA through the generation of these
highly reactive oxygen species. Extensive quercetin-induced
DNA damage via reaction with Cu(II) was reported. In an
electrochemical study of the DNA-Cu(II)-quercetin interac-
tions, several situations were studied using a bare GCE in
a solution containing dsDNA incubated with quercetin or
quercetin-Cu(II) complex and using a DNA-electrochemical
biosensor, which gave strong evidence that it was the radi-
cals formed during oxidation of the catechol moiety in the
Electrochemistry for Probing DNA Damage 9
quercetin molecule, via reaction with Cu(II) or electrochem-
ically, that damaged the DNA [115, 116].
The anticancer activity and host toxicity of compounds
with a quinone group was also investigated. There is con-
siderable death of tumour cells, together with the induction
of breaks in DNA single and double strands, although a
low binding value for the semiubiquinone with DNA was
found [117].
The antitumour action of the natural antibiotic bleomycin
is thought to involve the aerobic degradation of DNA by the
Fe2+-bleomycin complex. In order to probe the mechanism
of antitumor action of bleomycin, the 4-ethylamido[5,(2′-
thienyl)-2-thiophene] imidazole iron(II) complex was syn-
thesized [118]. It was studied in non-aqueous solution using
cyclic voltammetry and showed antitumour activity in vitro,
its action causing cleavage of the double helical DNA.
Spectroscopic methods have been complemented by elec-
trochemical methods in investigating the binding strength
and specificity of antineoplasic drugs with DNA at the
molecular level, as well as in explaining their toxic action.
Some tumour cells, but not normal cells, have nucleic acids
associated with the cell surface which can suppress many cell
immunological reactions.
The detection of chemicals that cause irreversible damage
to DNA is very important, as this may lead to hereditary or
carcinogenic diseases. A short-time screening test for car-
cinogens based on ac voltammetric measurements was devel-
oped to study in vitro damage to DNA caused by the action
of alkylating mutagens [119]. Nitroimidazoles are among the
most important nitroheterocyclic drugs of interest in cancer
chemiotherapy. It was observed that adenine and guanine
interact with intermediates generated during nitroimidazole
reduction [120], causing irreversible damage to DNA and
suggesting mutagenic properties of these compounds.
The mechanism of reduction of a group of nitroimida-
zoles: metronidazole, secnidazole and tinidazole was inves-
tigated using the DNA-biosensor [121–124] in a new way
by pre-concentrating the analyte on the electrode surface
containing DNA and studying either their reduction or
the oxidation of reduction products retained on the elec-
trode surface. It was possible to follow the reduction, and
the reversible reoxidation of the hydroxylamine derivative
(RNHOH) to the corresponding nitroso derivative (RNO),
as well as the condensation reaction between the hydroxy-
lamine and nitroso derivatives to form the azoxycompound
(RNO:NR) and the interaction with triple helix nucleic acid
(H-DNA). The DNA-biosensor contained a small amount
of H-DNA segments which were detected by the hydroxy-
lamine, a well known chemical probe for single strands in
H-DNA [125].
DNA-modified electrodes have also been used for trace
measurements of toxic amine compounds [126] and for trace
measurements of phenothiazine compounds with neurolep-
tic and antidepressive action [127] as well as for detection
of radiation-induced DNA damage [128].
Conventional cancer chemotherapy is as toxic as it is
beneficial. The DNA interacting drugs prevent cell growth,
but not only cancer cell growth and the cytotoxic effect
blocks also the growth of normal cells. The lack of selectiv-
ity of cancer drugs is one of the main problems in cancer
chemotherapy [129, 130] and the chemical and biological
mechanism of drugs active against cancer cells must be
investigated deeply.
Antisense and triplex-forming oligonucleotides are cur-
rently being developed as therapeutic agents for cancers and
viral infections [131]. They are highly effective and safe. The
recognition of the potential biological roles of H-DNA and
the interest in the triple-helical nucleic acid research also
includes genetic applications.
The potent antineoplasic antibiotic, also an antiviral and
antibacterial agent, the basic oligopeptide netropsin, is
known to increase the stiffening of double helical DNA seg-
ments to which it is bound. In agreement with this, voltam-
metric oxidation peaks at graphite electrodes of a DNA
solution containing netropsin were smaller for the peak cor-
responding to the oxidation of the adenine residues than
in solutions without netropsin [132]. These results show
the effect of the A.T-specific drug netropsin. Electrochem-
istry has the advantage of permitting direct observation of
changes in the A.T and G.C peaks in double stranded DNA
solutions with and without netropsin. This is a particularly
good example which demonstrates the relevance of electro-
chemistry for research into specific binding of biologically
active ligands to DNA.
The binding affinities of a group of cancerostatic anthra-
cycline antibiotics to DNA were evaluated by differential
pulse and other voltammetric techniques using mercury elec-
trodes [133] and the formation of complexes with DNA in
relation to the sugar residue was measured. It was found that
binding was higher for derivatives with two basic sugars and
lower for derivatives with one neutral sugar. Neverthless the
cytostatic properties of these anthracycline antibiotics also
depend on the influence of rates of dissociation, splitting
and transport to the DNA of the tumor.
Electrochemical voltammetric in situ detection of dsDNA
oxidative damage caused by reduced adriamycin, an antibi-
otic of the family of anthracyclines, intercalated into DNA,
was carried out using a DNA-electrochemical biosensor.
Oxidation and reduction of adriamycin molecules interca-
lated in dsDNA were investigated [14] in order to under-
stand the in vivo mechanism of action of DNA with this
anti-neoplasic drug. However, it is not possible to detect
adriamycin-DNA damage by monitoring only changes in
the adriamycin oxidation peak, Ep = +0.50 V, due to adri-
amycin’s strong adsorption [134]. The damage to immobi-
lized dsDNA causes the appearance of oxidation peaks from
DNA bases and this should always be measured and taken
into account, Figs. (7)B and (8)B.
Using a thin film of dsDNA, Fig. 7, the electrode is not
completely covered allowing non-specific adsorption of adri-
amycin molecules diffusing from the bulk solution to the
surface, giving an electrochemical signal with two contribu-
tions: from adsorbed adriamycin and from the adriamycin-
dsDNA interaction, Fig. 7(B), [14]. Using the thick film of
dsDNA, Fig. 8, the electrode surface is completely covered
by dsDNA so the DNA-biosensor response corresponds to
the adriamycin-dsDNA interaction, Fig. (8)B [14].
The results showed that the interaction of adriamycin
with dsDNA is potential-dependent. The reduction of
adriamycin, at Ep = −060 V, originates radicals that
damage dsDNA causing the contact between DNA gua-
nine, Ep = +078 V, and adenine Ep = +108 V, bases and
10 Electrochemistry for Probing DNA Damage
z:11.8 nm
y:1 µm
x:1 µm
DNA monolayer
A B
C
0.2 0.4 0.6 0.8 1.0
E/V vs. SCE
0.5 µA
GCE
Figure 7. (A) MAC mode AFM topographical image in air of thin film dsDNA-biosensor surface, prepared onto HOPG by 3 min free adsorption
from a solution of 60 g/ml dsDNA in pH 4.5 0.1 M acetate buffer electrolyte; three-dimensional view 1 m × 1 m scan size. (B) Background-
subtracted differential pulse voltammograms in pH 4.5 0.1 M acetate buffer obtained with a thin layer dsDNA-modified GCE after being immersed
during 10 min in a 1 M adriamycin solution and rinsed with water before the experiment in buffer: (•••) without applied potential; (—) subsequent
scan after applying a potential of −0.6 V during 120 s. Pulse amplitude 50 mV, pulse width 70 ms, scan rate 5 mV s−1. Reprinted with permission
from [14], A. M. Oliveira Brett et al., Talanta 56, 969 (2002). © 2002. (C) Scheme of DNA monolayer modified GCE with adsorbed adriamycin.
the electrode surface such that their oxidation is easily
detected. A mechanism for adriamycin reduction and oxi-
dation in situ when intercalated in dsDNA immobilized
onto the glassy carbon electrode surface was proposed.
This mechanism leads to the formation of the mutagenic
8-oxoguanine, Ep = +038 V, whose redox behavior was
studied [64, 66, 67].
The DNA-electrochemical biosensor can provide very rel-
evant information because the mechanisms of interaction of
DNA-drug at charged interfaces mimics better the in vivo
DNA-drug complex situation, where it is expected that DNA
will be in close contact with charged phospholipid mem-
branes and proteins, rather than when the interaction is
in solution. Complexes between short oligodeoxynucleotides
(ODN) with a variable dGxdCy base composition and
liposomes composed of the cationic lipid DOTAP (ODN
lipoplexes), which can be important for the understanding
and development of gene therapy vectors based on ODN
lipoplexes, were studied by differential pulse voltammetry at
a glassy carbon electrode [135, 136]. It was found that the
ODN base sequence influences the physicochemical proper-
ties of the lipoplexes. This means that DNA sequences are
not only essential, as they code for proteins and are relevant
for DNA/protein interaction and genetic regulation, but that
there is also a sequence dependence interaction between
DNA and the lipids in the cellular membrane.
DNA-biosensors have been used for trace measurements
of toxic amine compounds, phenothiazine compounds with
neuroleptic and antidepressive action as well as detection
of radiation-induced DNA damage [130]. Screening tests
for carcinogens based on voltammetric measurements were
developed to study in vitro damage to DNA caused by the
action of pollutants [137], pathogens [4] and detection of
DNA-adduct formation that start the carcinogenic process,
such as benzo[a]pyrene-DNA adducts [138]. The application
of DNA-electrochemical biosensors to detection in food of
bacterial and viral pathogens responsible for disease, due to
their unique nucleic acid sequences, is also attractive.
The development of electrochemical DNA-biosensors
opened a wide perspective using a particularly sensitive and
selective method for the detection of specific interactions.
The possibility of foreseeing the damage that these com-
pounds cause to DNA integrity arises from the possibil-
ity of pre-concentration of either the starting materials or
the redox reaction products on the DNA-biosensor surface,
thus permitting the electrochemical probing of the presence
of short-lived intermediates and of their damage to DNA
[14, 115, 116, 123–126].
Effectively, the DNA-electrochemical biosensor enables
pre-concentration of the drug under investigation onto the
electrode sensor surface and in situ electrochemical gener-
ation of radicals, which cause damage to the DNA immo-
bilized on the glassy carbon electrode surface and can be
detected electrochemically. The whole detection procedure
occurs in minutes.
However, non-uniform coverage of the electrode sur-
face by DNA and adsorption of drug on the bare GCE,
Fig. 7(C), may lead to contributions from both simple
adsorbed analyte and from the products of the damage
caused to dsDNA immobilized on the electrode surface,
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Figure 8. (A) MAC mode AFM topographical image in air of thick film dsDNA-biosensor surface, prepared onto HOPG by evaporation from
solution of 37.5 mg/ml dsDNA in pH 4.5 0.1 M acetate buffer electrolyte, three-dimensional view 1 m× 1 m nm scan size. (B) Differential pulse
voltammograms in pH 4.5 0.1 M acetate buffer solution, obtained with a GCE modified by a DNA multilayer, after being immersed during 10 min
in a 1 M adriamycin solution and washed with water before the scan in acetate buffer (•••) without applied potential; (—) after application of
−0.6 V during 120 s. v = 5mV s−1. Reprinted with permission from [14], A. M. Oliveira Brett, M. Vivian, I. R. Fernandes, and J. A. P. Piedade,
Talanta 56, 969 (2002). © 2002. (C) Scheme of DNA multilayer modified GCE with adsorbed adriamycin.
which need to be carefully distinguished. The damage to
immobilized DNA always leads to the appearance of oxi-
dation peaks from DNA easily oxidized bases, guanine and
adenine, or even 8-oxoguanine [64, 66, 67], which should be
monitored and taken into account.
The understanding of the mechanism of action of drugs
that interact with DNA will explain the differences in reac-
tivity between similar compounds. This knowledge can be
used as an important parameter for quantitative structure-
activity relationships (QSAR) and/or molecular modeling
studies, as a contribution to the design of new structure-
specific DNA-binding drugs, and for the possibility of pre-
screening the damage they may cause to DNA integrity.
5. CONCLUSIONS
Electrochemical research on DNA is of great relevance to
explain many biological mechanisms. The DNA-modified
electrode is a very good model for simulating the nucleic
acid interaction with cell membranes, potential environmen-
tal carcinogenic compounds and to clarify the mechanisms
of action of drugs used as chemotherapeutic agents.
The use of DNA-electrochemical biosensors for the
understanding of DNA interactions with molecules or ions
exploits the use of voltammetric techniques for in situ gen-
eration of reactive intermediates and is a complementary
tool for the study of biomolecular interaction mechanisms.
Voltammetric methods are an inexpensive and fast detection
procedure. Additionally, the interpretation of electrochemi-
cal data can contribute to elucidation of the mechanism by
which DNA is oxidatively damaged by such substances, in
an approach to the real action scenario that occurs in the
living cell.
The development of the DNA-electrochemical biosensor
has opened wide perspectives using a particularly sensitive
and selective method for the detection of specific interac-
tions. The possibility of foreseeing the damage that these
compounds cause to DNA integrity arises from the pre-
concentration of either the starting materials or the redox
reaction products on the DNA-biosensor surface, thus per-
mitting the electrochemical probing of the presence of short-
lived intermediates and of their damage to DNA.
GLOSSARY
Adenine a purine base that pairs with thymine in the DNA
double helix.
Adenosine the nucleoside containing adenine as its base.
AFM atomic force microscopy.
AMP adenosine monophosphate.
AP sites apurinic or apyrimidinic site resulting from the
loss of a purine or pyrimidine residue from DNA
Biosensor a device incorporating a biological sensing
element connected to a transducer.
Base pair two nucleotides inn DNA that are paired by
hydrogen bonds—for example, G with C and A with T.
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Bond energy strength of the chemical linkage between two
atoms, measured by the energy needed to break it.
Carcinogen agent, such as a chemical or a form of radia-
tion, that causes cancer.
Chromatography separation technique in which a mixture
of substances is separated by charge, size, or some other
property by allowing it to partition, between a moving phase
and a stationary phase.
Complementary nucleotide sequence two nucleic acid
sequences are said to be complementary if they can form a
perfect base-paired double helix with each other.
Cytidine the nucleoside having cytosine as its base.
Cytosine a pyrimidine base that pairs with guanine.
Denaturation change in conformation of a nucleic acid
caused by heating or by exposure to chemicals and usually
resulting in loss of biological function.
Deoxyribonucleic acid (DNA) polynucleotide formed from
covalently linked deoxyribonucleic units that serve as the
carrier of genetic information.
Diffusion movement of molecules in the direction of lower
concentration due to random thermal movements.
Double helix the structure of DNA first proposed by
Watson and Crick, with two interlocking helices joined by
hydrogen bonds between paired bases.
Functional group group of covalently linked atoms, such
as hydroxyl group (−OH) or amino group (−NH2), the
chemical behavior of which is well characterized.
GCE glassy carbon electrode.
CPE carbon paste electrode.
Guanine A purine base that pairs with cytosine.
Guanosine The nucleoside having guanine as its base.
HMDE hanging mercury drop electrode.
HPLC high pressure liquid chromatography.
HPLC-ECD HPLC with electrochemical detection.
HPLC-MS/MS HPLC with tandem mass spectrometry.
H-DNA triple helix nucleic acid.
Hydrogen bond A weak bond in which an atom shares an
electron with a hydrogen atom; hydrogen bonds are impor-
tant in the specificity of base pairing in nucleic acids.
In situ in place.
In vitro in an experimental situation outside the organism.
In vivo in a living cell or organism.
Lesion a damaged area in a gene (a mutant), or a chro-
mosome.
MAC mode AFM magnetic AC mode atomic force
microscopy.
Macromolecule A large polymer such as DNA.
Melting denaturation of DNA.
Mutagen an agent that is capable of increasing the muta-
tion rate.
Mutant an organism or cell carrying a mutation.
Mutant site the damaged or altered area within a mutated
gene.
Nanometer (nm) unit of length used to measure
molecules, 1 nm = 10−3 m = 10−9 m = 10 Å (angstroms).
Nitrogen bases types of molecules that form important
parts of nucleic acids, composed of nitrogen-containing ring
structures; hydrogen bonds between bases link the two
strands of a DNA double helix.
Nucleoside a nitrogen base bound to a sugar molecule.
Nucleotide a molecule composed of a nitrogen base, a
sugar, and a phosphate group; the basic building block of
nucleic acids.
Nucleotide pair a pair of nucleotides (one in each strand
of DNA) that are joined by hydrogen bonds.
Nucleotide-pair substitution the replacement of a specific
nucleotide pair by a different pair, often mutagenic.
8-oxodGuo 8-oxo-7,8-dihydro-2′deoxyguanosine.
8-oxoGua 8-oxo-7,8-dihydroguanine.
Phosphodiester bond a bond between a sugar group and
a phosphate group, such bonds form the sugar-phosphate
backbone of DNA.
Purine bases nitrogen-containing ring compounds found
in DNA called adenine and guanine.
Pyrimidine bases nitrogen-containing ring compounds
found in DNA called thymine and cytosine.
ROS reactive oxygen species.
QSAR quantitative structure-activity relationships.
Thymidine the nucleoside having thymine as its base.
Thymine a pyrimidine base that pairs with adenine.
UA uric acid.
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